The DOI matches its Crossref record.
Selective Downregulation of the Angiotensin II AT1-Receptor Subtype in Failing Human Ventricular Myocardium
Abstract
Background The regulation of angiotensin II receptors and the two major subtypes (AT 1 and AT 2) in chronically failing human ventricular myocardium has not been previously examined. Methods and Results Angiotensin II receptors were measured by saturation binding of 125 I-[Sar 1,Ile 8]angiotensin II in crude membranes from nonfailing (n=19) and failing human left ventricles with idiopathic dilated cardiomyopathy (IDC; n=31) or ischemic cardiomyopathy (ISC; n=21) and membranes from a limited number of right ventricles in each category. The AT 1 and AT 2 fractions were determined by use of an AT 1-selective antagonist, losartan. β-Adrenergic receptors were also measured by binding of 125 I-iodocyanopindolol with the β 1 and β 2 fractions determined by use of a β 1-selective antagonist, CGP20712A. AT 1 but not AT 2 density was significantly decreased in the combined (IDC+ISC) failing left ventricles (nonfailing: AT 1 4.66±0.48, AT 2 2.73±0.39; failing: AT 1 3.20±0.29, AT 2 2.70±0.33 fmol/mg protein; mean±SE). The decrease in AT 1 density was greater in the IDC than in the ISC left ventricles (IDC: 2.73±0.40,P<.01; ISC: 3.89±0.39 fmol/mg protein,P=NS versus nonfailing). β 1 but not β 2 density was decreased in the failing left ventricles. AT 1 density was correlated with β 1 density in all left ventricles (r=.43). AT 1 density was also decreased in IDC right ventricles. In situ reverse transcription–polymerase chain reaction in sections of nonfailing and failing ventricles indicated that AT 1 mRNA was present in both myocytes and nonmyocytes. Conclusions AT 1 receptors are selectively downregulated in failing human ventricles, similar to the selective downregulation of β 1 receptors. The relative lack of AT 1 downregulation in ISC hearts may be related to differences in the degree of ventricular dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Matsubara, H. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1182 · Cited by 478
Gray, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00121-7 · Cited by 417
Myosin heavy chain gene expression in human heart failure.
Nakao, K., Minobe, W., Roden, R., Bristow, M. R., & Leinwand, L. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119776 · Cited by 413
Self-citationLatini, R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.030 · Cited by 344
Angiotensin II Has Multiple Profibrotic Effects in Human Cardiac Fibroblasts
Kawano, H., Do, Y. S., Kawano, Y., Starnes, V., Barr, M., Law, R. E., & Hsueh, W. A. (2000) · Circulation · doi:10.1161/01.cir.101.10.1130 · Cited by 312
Zisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308
Self-citationVANDERVELDEN, J., PAPP, Z., ZAREMBA, R., BOONTJE, N., DEJONG, J., OWEN, V, BURTON, P., GOLDMANN, P., JAQUET, K., & STIENEN, G. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00606-5 · Cited by 301
Regulation of Angiotensin II Receptor Subtypes During Atrial Fibrillation in Humans
Goette, A., Arndt, M., Röcken, C., Spiess, A., Staack, T., Geller, J. C., Huth, C., Ansorge, S., Klein, H. U., & Lendeckel, U. (2000) · Circulation · doi:10.1161/01.cir.101.23.2678 · Cited by 280
Localization and function of angiotensin AT1 receptors.
ALLEN, A. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00249-6 · Cited by 278
Masaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1885 · Cited by 260
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Berry, C., Touyz, R., Dominiczak, A. F., Webb, R. C., & Johns, D. G. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2337 · Cited by 259
Mechanism of Action of Beta-Blocking Agents in Heart Failure
Bristow, M. R. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00846-1 · Cited by 259
Self-citationTsutsumi, Y., Matsubara, H., Ohkubo, N., Mori, Y., Nozawa, Y., Murasawa, S., Kijima, K., Maruyama, K., Masaki, H., Moriguchi, Y., et al. (1998) · Circulation Research · doi:10.1161/01.res.83.10.1035 · Cited by 241
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
Krombach, R. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00050-9 · Cited by 40
Metadata
- Authors
- Asano, K., Dutcher, D. L., Port, J. D., Minobe, W. A., Tremmel, K. D., Roden, R. L., Bohlmeyer, T. J., Bush, E. W., Jenkin, M. J., Abraham, W. T., Raynolds, M. V., Zisman, L. S., Perryman, M. B., & Bristow, M. R.
- Venue
- Circulation
- Published
- 1997-03-04
- Volume
- 95
- Issue
- 5
- Pages
- 1193-1200
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2020103404
- Cited by
- 168
- References
- 0
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.